The CancerConnect Cancer of Unknown Primary Newsletter

Stay Current With Cancer of Unknown Primary Treatment Advances & Connect with Others

CancerConnect Cancer of Unknown Primary Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Cancer of Unknown Primary. These are available in our monthly Cancer of Unknown Primary newsletter.

Stay Current - Connect With Other Cancer of Unknown Primary Patients

Join The CancerConnect Community: Connect with others and receive regular updates

or

Sarcoma

Fyarro for Malignant Perivascular Epithelioid Cell Tumor (PEComa)

The U.S. Food and Drug Administration (FDA) has approved FYARRO™ (sirolimus protein-bound particles for injectable suspension) (albumin-bound) for intravenous use for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa).

By CancerConnect

Nov 30, 2021

Renal Cancer Treatment

Radiofrequency Ablation Effective For Small Kidney Cancers

Radiofrequency ablation an an effective treatment for patients with small kidney cancers.

By Dr. C.H. Weaver M.D.

Nov 30, 2021

Surgery Vs Rfa

Sign up for the Cancer of Unknown Primary Newsletter Here